肾脏疾病对肝硬化患者预后的影响

摘要/Abstract

摘要： 肝硬化可导致一系列并发症,其中肾功能不全是常见的最严重的并发症,包括急性肾损伤(AKI)及慢性肾脏疾病 (CKD)。肾脏疾病可增加肝硬化的严重程度及病死率,即使血清肌酐(Cr)“正常”的肾病也有增加死亡的风险。早期控制肾脏疾病对肝硬化的预后至关重要,有望降低疾病的病死率,改善预后。本文就肾脏疾病对肝硬化患者预后的影响做一综述,旨在增强临床医生治疗肝硬化基础上发生的肾脏疾病的意识,并为肝硬化伴有肾脏疾病的临床治疗方面提供参考。

关键词: 急性肾损伤, 慢性肾脏疾病, 肝硬化, 预后

李琼, 毛小荣, 李俊峰, 侯贝贝. 肾脏疾病对肝硬化患者预后的影响[J]. 肝脏, 2022, 27(11): 1235-1238.

参考文献

[1] Bateman RM, Sharpe MD, Jagger JE, et al. 36th International Symposium on Intensive Care and Emergency Medicine : Brussels, Belgium. 15-18 March 2016. Crit Care. 2016. 20(Suppl 2): 94.
[2] Angeli P, Gines P, Wong F, et al. Diagnosis and management of acute kidney injury in patients with cirrhosis: revised consensus recommendations of the International Club of Ascites. Gut, 2015, 64(4):531-537.
[3] Tariq R, Hadi Y, Chahal K, et al. Incidence, Mortality and Predictors of Acute Kidney Injury in Patients with Cirrhosis: A Systematic Review and Meta-analysis. J Clin Transl Hepatol, 2020, 8(2):135-142.
[4] Fagundes C, Barreto R, Guevara M, et al. A modified acute kidney injury classification for diagnosis and risk stratification of impairment of kidney function in cirrhosis. J Hepatol, 2013, 59(3):474-481.
[5] Wong F, O'Leary J G, Reddy K R, et al. A cut-off serum creatinine value of 1.5 mg/dl for AKI--to be or not to be. J Hepatol. 2015, 62(3): 741-743.
[6] Tsien CD, Rabie R, Wong F. Acute kidney injury in decompensated cirrhosis. Gut, 2013, 62(1):131-137.
[7] Maiwall R, Sarin SK, Moreau R. Acute kidney injury in acute on chronic liver failure. Hepatol Int, 2016, 10(2):245-257.
[8] Guirguis J, Chhatwal J, Dasarathy J, et al. Clinical impact of alcohol-related cirrhosis in the next decade: estimates based on current epidemiological trends in the United States. Alcohol Clin Exp Res, 2015, 39(11):2085-2094.
[9] Makar M, Reja D, Chouthai A, et al. The impact of acute kidney injury on mortality and clinical outcomes in patients with alcoholic cirrhosis in the USA. Eur J Gastroenterol Hepatol, 2021, 33(6):905-910.
[10] Wong F, Reddy KR, Tandon P, et al. Progression of Stage 2 and 3 Acute Kidney Injury in Patients with Decompensated Cirrhosis and Ascites. Clin Gastroenterol Hepatol, 2021, 19(8):1661-1669.e2.
[11] Raveendran N, Beniwal P, D'Souza A V, et al. Profile of glomerular diseases associated with hepatitis B and C: A single-center experience from India. Saudi J Kidney Dis Transpl, 2017, 28(2): 355-361.
[12] Hiramine Y, Uto H, Mawatari S, et al. Impact of acute kidney injury on prognosis and the effect of tolvaptan in patients with hepatic ascites. J Gastroenterol, 2021, 56(1):54-66.
[13] Devani K, Charilaou P, Jaiswal P, et al. Trends in Hospitalization, Acute Kidney Injury, and Mortality in Patients with Spontaneous Bacterial Peritonitis. J Clin Gastroenterol, 2019, 53(2): e68-e74.
[14] Sohn W, Kim JH, Cho JY. Effect of acute kidney injury on long-term outcomes of spontaneous bacterial peritonitis in cirrhotic patients using the International Club of Ascites-acute kidney injury criteria. J Gastroenterol Hepatol, 2020, 35(5):870-876.
[15] Maiwall R, Kumar G, Bharadwaj A, et al. AKI persistence at 48 h predicts mortality in patients with acute on chronic liver failure. Hepatol Int, 2017, 11(6):529-539.
[16] Hsieh YC, Lee KC, Chen PH, et al. Acute kidney injury predicts mortality in cirrhotic patients with gastric variceal bleeding. J Gastroenterol Hepatol, 2017, 32(11):1859-1866.
[17] Hung TH, Tseng CW, Tseng KC, et al. Is end stage renal disease a risk factor for the mortality of cirrhotic patients with esophageal variceal bleeding? Hepatogastroenterology, 2014, 61(135):1871-1875.
[18] EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis. J Hepatol. 2018, 69(2): 406-460.
[19] Sarin SK, Choudhury A, Sharma MK, et al. Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific association for the study of the liver (APASL): an update. Hepatol IntHepatol Int, 2019, 13(4):353-390.
[20] Wong F, Nadim MK, Kellum JA, et al. Working party proposal for a revised classification system of renal dysfunction in patients with cirrhosis. Gut, 2011, 60(5):702-709.
[21] Péron JM, Bureau C, Gonzalez L, et al. Treatment of hepatorenal syndrome as defined by the international ascites club by albumin and furosemide infusion according to the central venous pressure: a prospective pilot study. Am J Gastroenterol, 2005, 100(12):2702-2707.
[22] Wong F, Reddy K R, O'Leary J G, et al. Impact of Chronic Kidney Disease on Outcomes in Cirrhosis. Liver Transpl, 2019, 25(6): 870-880.
[23] Cullaro G, Verna EC, Lai JC. Association Between Renal Function Pattern and Mortality in Patients with Cirrhosis. Clin Gastroenterol Hepatol, 2019, 17(11):2364-2370.
[24] Hung TH, Tsai CC, Hsieh YH, et al. Effect of renal impairment on mortality of patients with cirrhosis and spontaneous bacterial peritonitis. Clin Gastroenterol Hepatol, 2012, 10(6):677-681.
[25] Hung TH, Tsai CC, Tseng KC, et al. High Mortality of Cirrhotic Patients with End-Stage Renal Disease. Medicine (Baltimore), 2016, 95(10): e3057.
[26] Yang JY, Lee TC, Montez-Rath ME, et al. Trends in acute nonvariceal upper gastrointestinal bleeding in dialysis patients. J Am Soc Nephrol, 2012, 23(3):495-506.
[27] Amitrano L, Guardascione M A, Manguso F, et al. The effectiveness of current acute variceal bleed treatments in unselected cirrhotic patients: refining short-term prognosis and risk factors. Am J Gastroenterol. 2012, 107(12): 1872-1878.
[28] Solà E, Ginès P. Chronic Kidney Disease in Cirrhosis: Emerging Complication with Negative Impact in the Liver Transplant Setting. Liver Transpl, 2020, 26(4): 483-484.